For decades, cardiovascular exercise dominated longevity conversations, but mounting evidence is repositioning resistance training as an equally critical pillar of a long life. This large-scale analysis quantifies exactly how much weekly lifting is associated with meaningful mortality reductions — and where the returns plateau — giving health-conscious adults a rare dose-response map rather than vague guidance.
Drawing on three major U.S. prospective cohorts — the Health Professionals Follow-up Study and both Nurses' Health Studies — researchers tracked 147,374 participants over up to 30 years, recording 35,798 deaths. After adjusting for aerobic activity levels, 90–119 minutes per week of resistance training was associated with a 13% lower all-cause mortality risk (HR 0.87), a 19% lower cardiovascular mortality risk (HR 0.81), and a notably striking 27% lower neurological disease mortality risk (HR 0.73). Critically, no further benefit emerged above 120 minutes per week, suggesting a clear ceiling effect. Cancer mortality reduction followed a different, lower-dose pattern, appearing only at 1–59 minutes per week and diminishing at higher volumes. Joint analyses indicated that combining adequate aerobic activity with resistance training conferred additive protection beyond either modality alone.
This study's scale and duration are its primary strengths — three decades of follow-up across nearly 150,000 participants dwarfs most prior resistance training mortality work. The neurological mortality finding is particularly noteworthy and underexplored: mechanisms may involve improved insulin sensitivity, reduced neuroinflammation, or muscle-derived myokines that cross the blood-brain barrier. The cancer dose-response inversion — where more resistance training offered no additional cancer protection — warrants mechanistic investigation and may reflect immune or hormonal trade-offs at higher training volumes. Limitations include self-reported exercise data, a predominantly white, health-professional cohort limiting generalizability, and residual confounding inherent in any observational design. Still, the consistency of the dose-response curve and the specificity of cause-of-death findings elevate this beyond incremental work — it meaningfully sharpens existing physical activity guidelines.
